Feedback / Questions
dexpramipexole (KNS-760704) - Areteia Therapeutics
https://www.businesswire.com/news/home/20250916566261/en/Areteia-Therapeutics-Announces-Positive-Topline-Results-from-the-First-Phase-III-Study-of-Oral-Dexpramipexole-in-Eosinophilic-Asthma
Sep 16, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next